Use of Electronic Cigarettes to Aid Long-Term Smoking Cessation in the United States: Prospective Evidence From the PATH Cohort Study.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 12 2020
Historique:
received: 17 11 2019
revised: 17 07 2020
accepted: 21 07 2020
pubmed: 28 7 2020
medline: 1 1 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Electronic cigarettes (e-cigarettes) are the preferred smoking-cessation aid in the United States; however, there is little evidence regarding long-term effectiveness among those who use them. We used the Population Assessment of Tobacco and Health Study to compare long-term abstinence between matched US smokers who tried to quit with and without use of e-cigarettes as a cessation aid. We identified a nationally representative cohort of 2,535 adult US smokers in 2014-2015 (baseline assessment), who, in 2015-2016 (exposure assessment), reported a past-year attempt to quit and the cessation aids used, and reported smoking status in 2016-2017 (outcome assessment; self-reported ≥12 months continuous abstinence). We used propensity-score methods to match each e-cigarette user with similar nonusers. Among US smokers who used e-cigarettes to help quit, 12.9% (95% confidence interval (CI): 9.1%, 16.7%) successfully attained long-term abstinence. However, there was no difference compared with matched non-e-cigarette users (cigarette abstinence difference: 2%; 95% CI: -3%, 7%). Furthermore, fewer e-cigarette users were abstinent from nicotine products in the long term (nicotine abstinence difference: -4%; 95% CI: -7%, -1%); approximately two-thirds of e-cigarette users who successfully quit smoking continued to use e-cigarettes. These results suggest e-cigarettes may not be an effective cessation aid for adult smokers and, instead, may contribute to continuing nicotine dependence.

Identifiants

pubmed: 32715314
pii: 5876619
doi: 10.1093/aje/kwaa161
pmc: PMC7705599
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1529-1537

Subventions

Organisme : NCI NIH HHS
ID : R01 CA234539
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Références

J Am Stat Assoc. 2015 Apr 3;110(510):515-527
pubmed: 26273117
Nicotine Tob Res. 2019 Jan 1;21(1):41-47
pubmed: 29617887
Nicotine Tob Res. 2020 Apr 21;22(5):861-862
pubmed: 31398246
Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1443-1453
pubmed: 31239264
Nicotine Tob Res. 2020 Aug 24;22(9):1560-1568
pubmed: 31807784
J Natl Cancer Inst. 1997 Apr 16;89(8):572-6
pubmed: 9106646
Nicotine Tob Res. 2012 Dec;14(12):1483-7
pubmed: 22318689
J Natl Cancer Inst. 2018 Jun 1;110(6):581-587
pubmed: 29281040
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
Annu Rev Public Health. 2018 Apr 1;39:193-213
pubmed: 29323611
Drug Alcohol Depend. 2019 Jun 1;199:10-17
pubmed: 30978519
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Annu Rev Public Health. 2018 Apr 1;39:189-191
pubmed: 29323610
Drug Alcohol Depend. 2017 Sep 1;178:257-266
pubmed: 28675817
Am J Public Health. 2019 Jul;109(7):1000-1006
pubmed: 31095415
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
N Engl J Med. 2018 Jun 14;378(24):2302-2310
pubmed: 29791259
Am J Epidemiol. 2018 Nov 1;187(11):2397-2404
pubmed: 29955810
Tob Control. 2019 Jan;28(1):42-49
pubmed: 29574448
JAMA. 2019 Sep 16;:
pubmed: 31524940
Nicotine Tob Res. 2020 Apr 21;22(5):728-733
pubmed: 31298296
PLoS One. 2013 Dec 11;8(12):e81045
pubmed: 24349029
Addiction. 2015 Feb;110(2):346-55
pubmed: 25331778
Nicotine Tob Res. 2019 Feb 18;21(3):278-284
pubmed: 30346585
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
N Engl J Med. 2019 Oct 10;381(15):1490-1491
pubmed: 31532955
Tob Control. 2018 Jan;27(1):18-25
pubmed: 28970328

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH